Skip to main content

Table 1 Clinical findings of the 110 cases examined

From: Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue

Histological type

Mean age (years)

Sex

Site

Localized tenosynovial giant cell tumor (44)

47 (9–78)

M (21)

Digit (32)

  

F (23)

Hand (6)

   

Foot (5)

   

Knee (1)

Diffuse tenosynovial giant cell tumor (20)

36 (17–58)

M (5)

Knee (12)

  

F (15)

Hip (2)

   

Foot (2)

   

Shoulder (1)

   

Elbow (1)

   

Digit (1)

   

Vertebra (1)

Malignant tenosynovial giant cell tumor (1)

22

M (1)

Digit (1)

Giant cell tumor of bone (10)

43 (26–60)

M (1)

Femur (5)

  

F (9)

Tibia (3)

   

Humerus (1)

   

Radius (1)

Aneurysmal bone cyst (3)

15 (13–16)

M (1)

Fibula (1)

  

F (2)

Ilium (1)

   

Sacrum (1)

Giant cell reparative granuloma (2)

53 (31–75)

M (1)

Cranium (1)

  

F (1)

Jaw (1)

Undifferentiated pleomorphic sarcoma (10)

71 (62–87)

M (5)

Lower extremity (5)

  

F(5)

Trunk (3)

   

Upper extremity (1)

   

Shoulder (1)

Leiomyosarcoma (10)

81 (58–92)

M (4)

Lower extremity (6)

  

F (6)

Upper extremity (2)

   

Trunk (2)

Myxofibrsarcoma (10)

70 (47–88)

M (7)

Upper extremity (6)

  

F (3)

Lower extremity (4)

  1. M, male; F, female